- 期刊
Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Trial Literature
延伸閱讀
- Shen, C. C. (2011). Role of hepatocyte growth factor activator inhibitor type 2 in inhibiting Non-small-cell lung carcinoma cell invasion and down-regulation of epidermal growth factor receptor [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2011.01193
- 朱殷弘（2009）。Association of polymorphism of insulin-like growth factor genes with susceptibility to and severity of hepatocellular carcinoma〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2009.00041
- Hsu, H. H. (2006). Correlation of Epidermal Growth Factor Receptor Gene Mutations in Tumor Tissue and Clinical Chemosensitivity in Patients with Advanced Non-Small Cell Lung Cancer [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2006.03068
- Pekmezci, M., Szpaderska, A., Osipo, C., & Erşahin, Ç. (2012). The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma. Pathology Research International, 2012(), 336-342. https://doi.org/10.1155/2012/947041
- Przybyl, J., Jurkowska, M., Rutkowski, P., Rychter, M. D., & Siedlecki, J. A. (2012). Downstream and Intermediate Interactions of Synovial Sarcoma-Associated Fusion Oncoproteins and Their Implication for Targeted Therapy. Sarcoma, 2012(), 102-114. https://doi.org/10.1155/2012/249219